Re-Think Your Integrated CTMS: Why Moving to Unified Platform is the Only Path Forward

Feb 5, 2018

Most sponsors and clinical research organisations manage clinical trials using an average of three to five independent core systems. Creating duplicate data and processes in multiple systems impacts the seamless execution of clinical trials. To overcome this, industry leaders have tried point-to-point integration between the systems for decades. However this has complicated the process, and increased the overall operation burden and cost. In addition with point-to-point integrations systems industry struggle to adopt new trends like RBM and taking advantage of new technologies like cognitive computing.

The adoption of modern, unified drug development platforms would eliminate the bigger operational issues and increases the possibilities to leverage cloud and newer technologies like cognitive computing (machine learning and artificial intelligence)

Featured Topics

  • Historic barriers of heterogeneous, point-to-point integrated systems
  • Decoding interconnected clinical trial processes
  • Challenges of integrated solutions
  • Principles of unified solution
  • Benefits of unified solution

Learning Objectives:

  • Analyze the adaptive nature of clinical trials
  • Describe the synergies of interconnected clinical processes
  • Discuss the challenges of implementing and managing integrated solutions
  • Explain the advantages of adopting a unified solution

[contact-form-7 id=”10062″ title=”Contact form for webinar”]

LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com